CoreCap Advisors’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
AA
CoreCap Advisors's PGEN Position: Q3 2026 in Review
CoreCap Advisors held its Precigen (PGEN) position steady in Q3 2026 at 500 shares worth $4.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2297.
CoreCap Advisors first reported a position in PGEN in Q1 2025 and has held it in 7 quarters since. 29 funds tracked by Wall St. Rank hold PGEN as of Q3 2026.
- CoreCap Advisors held 500 shares of Precigen worth $4.28K as of Q3 2026.
- CoreCap Advisors left its Precigen share count unchanged in Q3 2026.
- Precigen made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2297 holding.
- CoreCap Advisors first reported a position in Precigen in Q1 2025 and has held it in 7 quarters since.
- 29 funds tracked by Wall St. Rank held Precigen as of Q3 2026.
Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.